(+)-Rutamarin; 13164-05-1; S-(+)-Chalepin acetate; Rutamarin, (+)-; HSZ140D583; 2-[(2S)-6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrofuro[3,2-g]chromen-2-yl]propan-2-yl acetate; UNII-HSZ140D583; 3pcu; NSC-263654; CHEBI:8920; CHEMBL3577084; CHALEPIN ACETATE, (+)-; DTXSID10927299; ZINC1558484; (S)-2-(1-(Acetyloxy)-1-methylethyl)-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-7H-furo(3,2-g)(1)benzopyran-7-one; 7H-Furo(3,2-g)(1)benzopyran-7-one, 2-(1-(acetyloxy)-1-methylethyl)-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (S)-; C09308; Q27108191; (2S)-2-(1-(ACETYLOXY)-1-METHYLETHYL)-6-(1,1-DIMETHYL-2-PROPEN-1-YL)-2,3-DIHYDRO-7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE; 2-[6-(2-Methylbut-3-en-2-yl)-7-oxo-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-2-yl]propan-2-yl acetate; 7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE, 2-(1-(ACETYLOXY)-1-METHYLETHYL)-6-(1,1-DIMETHYL-2-PROPEN-1-YL)-2,3-DIHYDRO-, (2S)-